A global assessment of the oesophageal adenocarcinoma epidemic
暂无分享,去创建一个
H. Adami | E. Weiderpass | O. Nyrén | G. Edgren | Elisabete Weiderpass | Hans-Olov Adami | Olof Nyrén | Gustaf Edgren | O. Nyren
[1] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[2] Bjørn Møller,et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. , 2009, European journal of cancer.
[3] L. Liang,et al. Enigmatic sex disparities in cancer incidence , 2012, European Journal of Epidemiology.
[4] S. Spechler,et al. The increasing frequency of adenocarcinoma of the esophagus , 1989, Cancer.
[5] H. Welch,et al. Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[6] C. Abnet,et al. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH–AARP Diet and Health Study , 2011, Gut.
[7] P. Sparén,et al. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden , 1993, International journal of cancer.
[8] D. Hunter,et al. Textbook of cancer epidemiology , 2003 .
[9] L. Holmberg,et al. The completeness of the Swedish Cancer Register – a sample survey for year 1998 , 2009, Acta oncologica.
[10] S. Sabatino,et al. Trends in esophageal cancer incidence by histology, United States, 1998–2003 , 2008, International journal of cancer.
[11] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.
[12] F. Islami,et al. Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis , 2008, Cancer Prevention Research.
[13] S. Davis,et al. Incidence of cancer of the esophagus in the US by histologic type , 1988, Cancer.
[14] M. Oldendorf,et al. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007 , 2009, European Journal of Epidemiology.
[15] Jacques Ferlay,et al. Trends in oesophageal cancer incidence and mortality in Europe , 2007, International journal of cancer.
[16] H. Sørensen,et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.
[17] Anthony J. Swerdlow,et al. Cancer Registration in England and Wales: Some Aspects Relevant to Interpretation of the Data , 1986 .
[18] Jesper Lagergren,et al. Influence of obesity on the risk of esophageal disorders , 2011, Nature Reviews Gastroenterology &Hepatology.
[19] D. Antonioli,et al. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. , 1986, Human pathology.
[20] C. McConkey,et al. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. , 1990, British Journal of Cancer.
[21] D. Brewster,et al. Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992. , 1997, Public health.
[22] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.
[23] L. Murray,et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. , 2010, European journal of cancer.
[24] F. Bray,et al. Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries , 2005, Cancer Epidemiology Biomarkers & Prevention.
[25] C. Papi,et al. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial , 1995, Alimentary pharmacology & therapeutics.
[26] E. Kuipers,et al. Increasing incidence of Barrett’s oesophagus in the general population , 2005, Gut.
[27] T. Shimosegawa,et al. Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats , 2011, Gut.
[28] M. Coleman,et al. Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales , 2008, The American Journal of Gastroenterology.
[29] A. Gavin,et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.
[30] H. Welch,et al. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.
[31] J. Lagergren,et al. No further increase in the incidence of esophageal adenocarcinoma in Sweden , 2011, International journal of cancer.
[32] D Clayton,et al. Models for temporal variation in cancer rates. II: Age-period-cohort models. , 1987, Statistics in medicine.
[33] J. Mission,et al. Textbook of Cancer Epidemiology , 2004 .
[34] B Carstensen,et al. Age–period–cohort models for the Lexis diagram , 2007, Statistics in medicine.
[35] R. Simon,et al. Flexible regression models with cubic splines. , 1989, Statistics in medicine.
[36] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[37] R. Pounder,et al. The prevalence of Helicobacter pylori infection in different countries. , 1995, Alimentary pharmacology & therapeutics.
[38] H. Storm,et al. The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.
[39] M. Lehtonen,et al. Data quality and quality control of a population-based cancer registry. Experience in Finland. , 1994, Acta oncologica.
[40] W. Chow,et al. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. , 2008, Journal of the National Cancer Institute.
[41] H. El‐Serag. Time trends of gastroesophageal reflux disease: a systematic review. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[42] P. A. van den Brandt,et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe , 2009, European journal of gastroenterology & hepatology.
[43] K. McColl,et al. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia , 2010, Gut.
[44] Peter D Siersema,et al. Esophageal cancer. , 2008, Gastroenterology clinics of North America.
[45] F. Mégraud,et al. The cohort effect and Helicobacter pylori. , 1993, The Journal of infectious diseases.
[46] D Clayton,et al. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. , 1987, Statistics in medicine.
[47] J. Parsonnet,et al. Helicobacter pylori Infection and Gender: A Meta-Analysis of Population-Based Prevalence Surveys , 2006, Digestive Diseases and Sciences.
[48] A. Lindgren,et al. Disparities in the Classification of Esophageal and Cardia Adenocarcinomas and Their Influence on Reported Incidence Rates , 2006, Annals of surgery.
[49] V. Moreno,et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995 , 2002, International journal of cancer.
[50] A. Gavin,et al. Increasing incidence of Barrett’s oesophagus: a population-based study , 2011, European Journal of Epidemiology.
[51] C. Abnet,et al. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. , 2010, European journal of cancer.
[52] E. Kuipers,et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study , 2010, Gut.
[53] W. Chow,et al. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005 , 2009, British Journal of Cancer.
[54] S. Davis,et al. Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. , 1988, International journal of epidemiology.